Five Prime Therapeutics, Inc.
FPRX
FPRX was delisted on the 15th of April, 2021.
128 hedge funds and large institutions have $920M invested in Five Prime Therapeutics, Inc. in 2015 Q4 according to their latest regulatory filings, with 31 funds opening new positions, 43 increasing their positions, 42 reducing their positions, and 13 closing their positions.
160% more capital invested
Capital invested by funds: $354M → $920M (+$566M)
138% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 13
67% more funds holding in top 10
Funds holding in top 10: 3 → 5 (+2)
15% more funds holding
Funds holding: 111 → 128 (+17)
2% more repeat investments, than reductions
Existing positions increased: 43 | Existing positions reduced: 42
74% less call options, than puts
Call options by funds: $3.74M | Put options by funds: $14.4M
Top Buyers
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$28.9M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$22M |
| 3 |
RI
RTW Investments
New York
|
-$15.3M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$13.4M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
-$11.4M |
FPRX Hedge Fund Activity: Q4 2015 in Review
128 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in Five Prime Therapeutics, Inc. (FPRX) for Q4 2015, worth a combined $920M — up 160% from $354M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new FPRX positions and 13 closed out — a net gain of 18 holders — while 43 added to existing stakes and 42 trimmed.
The largest buyer was Deerfield Management, opening a new position worth an estimated $22.8M. The largest seller was State Street, cutting an estimated $28.9M.
- 128 institutional investors held Five Prime Therapeutics, Inc. (FPRX) as of Q4 2015, up from 111 in Q3 2015.
- Funds reported $920M of Five Prime Therapeutics, Inc. stock for Q4 2015, up 160% quarter-over-quarter.
- 31 funds opened new Five Prime Therapeutics, Inc. positions in Q4 2015 and 13 closed out, a net change of +18 holders.
- The largest Five Prime Therapeutics, Inc. buyer in Q4 2015 was Deerfield Management, an estimated $22.8M added.
- The largest Five Prime Therapeutics, Inc. seller in Q4 2015 was State Street, an estimated $28.9M sold.
Based on aggregated 13F filings for Q4 2015.